(3-214) Silmitasertib (CX-4945) Facilitates Proteasome-Mediated Degradation of Estrogen Receptor (ER) and Alters the Expression of a Panel of Genes Involved in Estrogen Receptor Signaling Pathway
Monday, December 5, 2022
12:00 PM – 1:00 PM
Location: Bayside A, Level 1
Category: Evaluative Study Topic: Investigational Drugs
Co-Author(s): Cameron Stevenson-Monroe, Christopher Willi
Primary Author(s)
Bo Cao
Pharmacy Student Xavier University of Louisiana, Louisiana